URGN:NASDAQ
Urogen Pharma Ltd
$34.15
arrow_downward
-1.19%(-0.41) 1D
$34.15
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for URGN...
Open
$34.75
High
$35.48
Low
$33.40
Mkt. cap
1.67B
Avg. vol.
915.27K
Volume
1.27M
52-wk high
$50.81
52-wk low
$16.36
EPS
-$1.98
Beta
1.57
Shares outstanding
48.88M
No. of employees
300
Open
$34.75
High
$35.48
Low
$33.40
Mkt. cap
1.67B
Avg. vol.
915.27K
Volume
1.27M
52-wk high
$50.81
52-wk low
$16.36
EPS
-$1.98
Beta
1.57
Shares outstanding
48.88M
No. of employees
300
News stories
From web sources and news partners
GuruFocus
·
7 hours ago
URGN Reiterated by HC Wainwright & Co. -- Price Target Maintained at $75
Investing.com
·
10 hours ago
FDA accepts UroGen’s drug application for bladder cancer
Stock Titan
·
11 hours ago
A bladder cancer drug candidate had a 77.8% complete response rate at three months.
About Urogen Pharma Ltd
CEO-
Employees300
Founded2004
HeadquartersNew York, New York, United States
SectorBiotechnology
Websiteurogen.com